Determination of Tenoxicam in Human Plasma using Solid-Phase Extraction and High-Performance Liquid Chromatography with Ultraviolet Detection
- 1 March 1992
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 15 (4) , 683-695
- https://doi.org/10.1080/10826079208018826
Abstract
A sensitive, specific and rapid liquid chromatographic procedure to selectively monitor tenoxicam in human plasma was developed and validated. Plasma samples were acidified and extracted using solid-phase exctration column. The procedure was linear from 0.1 to 10 μ.g/ml with a detection limit of 0.05μg/ml. The coefficient of variation for the procedure is 6.2% and 2.0% for the range of concentrations examinated. This method is suitable for pharmacological, toxicological and pharmacokinetic studies of tenoxicam.Keywords
This publication has 4 references indexed in Scilit:
- The Evolution of Non-Steroidal Anti-Inflammatory Drugs and their Mechanisms of ActionDrugs, 1987
- Pharmacokinetics of Tenoxicam after oral administration in healthy human subjects of various single dosesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1987
- Rapid method for the determination of either piroxicam or tenoxicam in plasma using high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Determination of Ro12-0068, a new anti-inflammatory and analgesic compound, in plasma by means of high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981